Patient decision aids

Shared decision making is a process in which clinicians and patients work together to choose test, treatment, management or support packages, based on clinical evidence and the patient’s informed preferences. Research shows strong proven benefits from shared decision making, including: greater knowledge, more accurate risk perception, greater comfort in decisions, fewer people remaining undecided and no increase in anxiety.
Roy Castle Lung Cancer Foundation, in partnership with British Thoracic Oncology Group (BTOG), National Lung Cancer Forum for Nurses (NLCFN) and Lilly, has produced a series of patient decision aids (PDAs) on adjuvant chemotherapy for lung cancer. Each PDA has been developed using a systematic process which follows International Patient Decision Aid Standards Collaboration guidance.

Chemotherapy after Surgery (Stage 2)
Chemotherapy after Surgery (Stage 3)
Guidance for healthcare professionals


Was this helpful?   
Yes (60)
No (46)
Contact us
Call us now 0333 323 7200